Itopul Tablet (Itopride Hydrochloride)

Adult dose

Adults: Administer itopride hydrochloride 50 mg orally 3 times daily before meals. Adjust the dose as needed according to symptoms.

This medication should not be used in patients who have had an allergic reaction to this medication or its ingredients. It should be avoided in patients with gastrointestinal bleeding, intestinal obstruction, or perforation, as it may stimulate gastrointestinal motility. Furthermore, this medication contains lactose; therefore, it should not be used in patients with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. During the use of this medication, rare but serious allergic reactions such as shock or anaphylaxis may occur. If symptoms such as hypotension, difficulty breathing, or hives appear, administration should be stopped immediately and appropriate treatment should be initiated. Liver dysfunction or jaundice symptoms may also occur, so liver function tests should be monitored closely. Gastrointestinal symptoms such as abdominal pain, nausea, diarrhea, constipation, and increased salivation may occur, and neurological symptoms such as headache, anxiety, sleep disturbances, and dizziness may also be experienced. Gynecomastia or elevated prolactin levels may occur, hence administration should be stopped if any abnormal signs are observed. Blood abnormalities such as thrombocytopenia or leukopenia may also occur, necessitating regular blood tests. There may be an increase in BUN or creatinine levels during kidney function tests, so caution is needed. This medication enhances the action of acetylcholine; therefore, when taken with anticholinergics, its effect may be reduced, so it is advisable to space out the doses if taken together. Pregnant women or those who may become pregnant should use this medication only when the benefits of treatment are judged to outweigh the risks, as its safety has not been established. If breastfeeding, this medication could be excreted into breast milk, so it should be avoided if possible; if necessary, breastfeeding should be discontinued. Due to insufficient safety data or potential for adverse reactions in children or the elderly with diminished physical function, careful observation is required when administering this medication. This medication should be stored out of reach of children, and care should be taken not to transfer it to another container, as this could lead to accidents and negatively impact the quality of the medication.

• Shock
• anaphylaxis-like symptoms
• hypotension
• difficulty breathing
• laryngeal edema
• urticaria
• pallor
• sweating
• liver dysfunction
• jaundice

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle